International Land Alliance (OTCQB:ILAL) on Wednesday said it has implemented a 50-for-1 reverse split of its common stock, effective February 4. The company’s shares will trade on a post-split basis under the temporary symbol “ILALD” for 20 days. The reverse split is part of International Land Alliance’s plan to pursue an uplisting to Nasdaq. Under the reverse split, every 50 outstanding shares w...
International Land Alliance (OTCQB:ILAL) on Wednesday said it has implemented a 50-for-1 reverse split of its common stock, effective February 4. The company’s shares will trade on a post-split basis under the temporary symbol “ILALD” for 20 days. The reverse split is part of International Land Alliance’s plan to pursue an uplisting to Nasdaq. Under the reverse split, every 50 outstanding shares were consolidated into one share. Fractional shares were rounded up to the nearest whole share. The action does not change shareholders’ proportional ownership or the par value of the stock. International Land Alliance’s shares trade on the OTCQB market. ILALD -2.5% after hours to $9.75. Source: Press Release More on International Land Alliance International Land Alliance secures up to $50M in institutional financing Seeking Alpha’s Quant Rating on International Land Alliance Financial information for International Land Alliance
Sue Thatcher/iStock Editorial via Getty Images Toyota Motor ( TM ) is planning a roughly 30% increase in production of hybrid and plug-in hybrid vehicles by 2028. The Japanese automaker's target is for about 6.7 million electrified units a year, according to reports. This would lift its overall global vehicle output to about 11.3 million units in 2028, around 10% above its 2026 plan, and raise the...
Sue Thatcher/iStock Editorial via Getty Images Toyota Motor ( TM ) is planning a roughly 30% increase in production of hybrid and plug-in hybrid vehicles by 2028. The Japanese automaker's target is for about 6.7 million electrified units a year, according to reports. This would lift its overall global vehicle output to about 11.3 million units in 2028, around 10% above its 2026 plan, and raise the share of hybrids in its lineup to about 60% from roughly 50% in 2026, according to Nikkei Asia. Toyota's ( TM ) plans include expanding hybrid production in the U.S., amid sustained demand for the Camry sedan and Tacoma pickup. The development underscores the auto giant's deepening emphasis on hybrids amid mixed demand for fully electric vehicles. Toyota ( TM ) already held a dominant market share position in the hybrid vehicle market of 58% to easily outdistance Honda ( HMC ) and Hyundai (HYMTF). The company entered the global hybrid vehicle market in 1997 when the first-generation Prius was sold. Since then, Toyota ( TM ) has effectively dominated the hybrid market. Shares of Toyota ( TM ) are up 8.1% on a year-to-date basis. More on Toyota Motor Toyota: Up Almost 10% With Plenty Of Road Left Ahead Japan's Industrial Push: Why Toyota Could Be A Long-Term Beneficiary Toyota Motor Corporation (TM) Discusses Achievements and Highlights at Tokyo Auto Salon Special Talk Show Prepared Remarks Transcript Toyota recalling more than 160K U.S. vehicles over camera display issue The world’s strongest brands in 2025, ranked
Wigmore Hall, London This young Berlin-based quartet impressed in a polished recital that built on Webern and Mendelssohn towards Beethoven’s enigmatic 0p 131 Even by the standards of Beethoven’s late quartets, his String Quartet No 14 in C sharp minor Op 131 is a strange piece. Opening with a lengthy fugue, it sprawls across seven movements – although one lasts only 11 bars and several run straig...
Wigmore Hall, London This young Berlin-based quartet impressed in a polished recital that built on Webern and Mendelssohn towards Beethoven’s enigmatic 0p 131 Even by the standards of Beethoven’s late quartets, his String Quartet No 14 in C sharp minor Op 131 is a strange piece. Opening with a lengthy fugue, it sprawls across seven movements – although one lasts only 11 bars and several run straight into each other. Moods shift quixotically. Motifs are obsessively repeated and developed. Beethoven supposedly considered it his finest quartet, but two centuries later this remains a work that asks a lot of its listener as well as its performers. No surprise, then, that the Berlin-based Leonkoro Quartet programmed this particular monument for their latest Wigmore Hall appearance since being shot to prominence with multiple wins in the 2022 Wigmore Hall International String Quartet competition . It’s an intensely serious statement of ambition from a group whose newest member was born in 2006 and who have recently garnered rave reviews for their second album. Continue reading...
Ukrainian sumo star Aonishiki Arata is eyeing the grand title of yokozuna after winning his second-straight Japanese championship on January 25. The wrestler fled Ukraine for Japan in 2022, narrowly avoiding the military draft. He has since risen rapidly through the ranks in sumo wrestling, adopting the name Aonishiki, which means “blue brocade” in honour of Ukraine.
Ukrainian sumo star Aonishiki Arata is eyeing the grand title of yokozuna after winning his second-straight Japanese championship on January 25. The wrestler fled Ukraine for Japan in 2022, narrowly avoiding the military draft. He has since risen rapidly through the ranks in sumo wrestling, adopting the name Aonishiki, which means “blue brocade” in honour of Ukraine.
Fox ( FOX ) declared $0.28/share semi-annual dividend , in line with previous. Forward yield 0.89% Payable March 25; for shareholders of record March 4; ex-div March 4. See FOX Dividend Scorecard, Yield Chart, & Dividend Growth. More on Fox FOXA: The Main Street Sports Group Challenge Presents Opportunity Wall Street Lunch: Fox's FanDuel Call Option Emerges As Hidden Growth Lever Risks Grow, But F...
Fox ( FOX ) declared $0.28/share semi-annual dividend , in line with previous. Forward yield 0.89% Payable March 25; for shareholders of record March 4; ex-div March 4. See FOX Dividend Scorecard, Yield Chart, & Dividend Growth. More on Fox FOXA: The Main Street Sports Group Challenge Presents Opportunity Wall Street Lunch: Fox's FanDuel Call Option Emerges As Hidden Growth Lever Risks Grow, But Fox Poised For Continued Gains Will Fox execute on its option to buy a large stake in FanDuel in 2026?
hapabapa/iStock Editorial via Getty Images Bristol-Myers Squibb's ( BMY ) guidance for the current year will be in focus as the drugmaker reports Q4 earnings on Thursday, February 5, before the market opens. Wall Street expects EPS of $1.21 , down 27.5% Y/Y, on revenue of $12.28B, representing a modest 0.2% Y/Y decline. While earnings are projected to fall sharply from a year ago, Bristol-Myers ha...
hapabapa/iStock Editorial via Getty Images Bristol-Myers Squibb's ( BMY ) guidance for the current year will be in focus as the drugmaker reports Q4 earnings on Thursday, February 5, before the market opens. Wall Street expects EPS of $1.21 , down 27.5% Y/Y, on revenue of $12.28B, representing a modest 0.2% Y/Y decline. While earnings are projected to fall sharply from a year ago, Bristol-Myers has a strong track record of execution, having beaten both EPS and revenue estimates in every quarter over the past two years. Estimate trends, however, are mixed heading into the release. Over the past three months, EPS forecasts have seen two upward revisions and 14 downward, while revenue expectations have moved in the opposite direction, logging 14 upward revisions and just two cuts. Bristol-Myers Squibb ( BMY ) shares have dropped 5.3% over the past year, substantially lagging the broader U.S. market, amid concerns over looming patent expirations. The drugmaker is working to offset the impact through acquisitions, pipeline growth, and strategic product extensions. Investors will be focused on key product trends, particularly Eliquis, the blood thinner co-marketed with Pfizer ( PFE ), and Revlimid, the multiple myeloma therapy that has faced generic competition since 2022. Revlimid (lenalidomide) posted a sharp 59% Y/Y revenue decline in Q3, while Eliquis sales climbed nearly 25% Y/Y. Pomalyst/Imnovid (pomalidomide), another multiple myeloma treatment expected to face generic entry in Q1 2026, also saw sales fall 25% Y/Y in Q3. On the growth side, attention will center on Opdivo, Bristol Myers Squibb’s flagship oncology drug, which continues to deliver steady growth despite looming patent expirations in Europe in 2026 and the U.S. in 2028. Opdivo revenue rose about 7% to $2.5B in the most recent quarter. More on Bristol-Myers Squibb Company Bristol Myers Squibb: The Rerating Was Fast - The Proof Will Be Slow (Rating Downgrade) Bristol-Myers Squibb: Solid Tumor Collaborati...
The coffee shop chain's stock continues to slide. Shares of Dutch Bros (BROS 4.09%) stock dropped 11% in January, according to data provided by S&P Global Market Intelligence. There wasn't any news specific to the coffee shop company, but the stock has been sliding over the past few months as the market worries about the strength of the U.S. consumer. Great coffee, fast service Dutch Bros' model i...
The coffee shop chain's stock continues to slide. Shares of Dutch Bros (BROS 4.09%) stock dropped 11% in January, according to data provided by S&P Global Market Intelligence. There wasn't any news specific to the coffee shop company, but the stock has been sliding over the past few months as the market worries about the strength of the U.S. consumer. Great coffee, fast service Dutch Bros' model is based around speed, service, and a fun environment. Its store fleet is almost entirely drive-thru, but its broistas walk through the lanes taking orders, which creates a connection and gets orders prepared quickly. It offers a wide range of exclusive custom beverages, as well as an expanding food menu that complements different parts of the day. The concept is taking off. The company has grown from a small chain of Oregon-based stores to about 500 West Coast stores at initial public offering (IPO) and more than 1,000 stores today. That's doubling over the past four years, and it's aiming to double again over the next four years, reaching 2,029 stores by 2029. Longer term, management envisions operating 7,000 stores nationwide, and it keeps expanding its presence in new states. So far, it's unfolding into an exciting story. Sales continue to increase at a rapid pace, up 25% year over year in the 2025 third quarter. Comparable sales were up 5.7%, with a 4.7% increase in transactions. It's also becoming highly profitable, with $27.3 million in net income in the third quarter, up from $21.7 million the previous year. The company is in growth mode, and in addition to opening new stores, it's building a robust membership program and mobile ordering. Since it's young and agile, it's also developing an efficient real estate plan. Expand NYSE : BROS Dutch Bros Today's Change ( -4.09 %) $ -2.28 Current Price $ 53.49 Key Data Points Market Cap $6.8B Day's Range $ 52.15 - $ 55.69 52wk Range $ 47.16 - $ 86.88 Volume 8.3K Avg Vol 3.9M Gross Margin 26.17 % Can the stock go back up? Whil...
Michael Vi/iStock Editorial via Getty Images AbbVie ( ABBV ) posted better-than-expected financials for Q4 2025 as the company’s former best seller, Humira, exceeded Street forecasts, offsetting a mixed performance from its newer immunology drugs, Rinvoq and Skyrizi. The company reported $16.6B in revenue for the quarter with ~10% YoY growth, exceeding the consensus by $200M, as its Humira net rev...
Michael Vi/iStock Editorial via Getty Images AbbVie ( ABBV ) posted better-than-expected financials for Q4 2025 as the company’s former best seller, Humira, exceeded Street forecasts, offsetting a mixed performance from its newer immunology drugs, Rinvoq and Skyrizi. The company reported $16.6B in revenue for the quarter with ~10% YoY growth, exceeding the consensus by $200M, as its Humira net revenue reached $1.2B compared to $993.8M projected by analysts, according to Bloomberg data. Meanwhile, Rinvoq and Skyrizi added $2.37B and $5.00B to the topline with ~30% YoY and ~33% YoY growth, respectively, compared to $2.38B and $4.9B in the consensus, while Humira sales dropped ~26% amid generic competition. Therapeutic and cosmetic versions of its anti-wrinkle product, Botox, generated $990M and $717M with ~13% YoY and ~4% YoY growth, respectively, while cancer therapy Imbruvica added $671M to the topline, missing $705.3M in the consensus. For the full year, the company recorded $61.6B in net revenue with ~9% YoY growth, while its adjusted diluted EPS slipped ~1% YoY to $10.00 amid a $2.76 impact related to acquired R&D and other expenses. During the quarter, ABBV’s adjusted gross and operating margins reached 83.6% and 38.3%, respectively, in comparison to 83.8% and 34.7% in the prior year period. Meanwhile, its adjusted diluted EPS stood at $2.71 in Q4 with ~26% YoY growth, and for 2026, the company projected $14.37 - $14.57 of adjusted EPS, beating $14.22 in the consensus. More on AbbVie AbbVie Inc. (ABBV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript AbbVie: The Dividend Does Not Lie AbbVie: Rocky Near-Term, Positive Long-Term AbbVie Non-GAAP EPS of $2.71 beats by $0.06, revenue of $16.62B beats by $200M AbbVie Q4 Preview: Here's what to expect
It's not fun to buy a stock when the price keeps dropping, but it could be worth your while in this case. Last year was a fantastic year for the S&P 500, but not all companies in the famous stock market index fared well. The Trade Desk (TTD 8.69%), one of the index's newest members, has been in a terrible slump. The stock declined by a whopping 67% in 2025 and kicked off this year by declining ano...
It's not fun to buy a stock when the price keeps dropping, but it could be worth your while in this case. Last year was a fantastic year for the S&P 500, but not all companies in the famous stock market index fared well. The Trade Desk (TTD 8.69%), one of the index's newest members, has been in a terrible slump. The stock declined by a whopping 67% in 2025 and kicked off this year by declining another 20%. The Trade Desk is one of the world's leading adtech companies. Its software platform helps match advertisers with their ideal audience for advertising campaigns across digital media. The company has thrived as an alternative to Meta Platforms and Alphabet, industry juggernauts that dominate and tightly control advertising on social media and search. Despite its downfall, the stock has still outperformed the broader market over its lifetime. Should you buy The Trade Desk? Or is this ongoing slump a flashing warning sign? Stocks don't typically decline this much for no reason Unfortunately, The Trade Desk's decline isn't a fluke. The truth is that multiple factors have contributed to the stock's downfall. For starters, The Trade Desk was one of Wall Street's hottest stocks at one point, with a sky-high valuation that was difficult to sustain. At its peak in late 2024, The Trade Desk traded at 85 times its forward earnings estimates. If it weren't for that, the stock probably wouldn't have plummeted as it has. Then, the competitive landscape heated up throughout 2025. Amazon has become an emerging heavyweight in digital advertising, launching a competing platform and partnering with Netflix for its ad-supported membership tier. The Trade Desk's revenue growth has slowed for several quarters now, an awful development for an expensive growth stock. The Trade Desk is still struggling to regain Wall Street's confidence. It recently fired its new chief financial officer after just months on the job, which hasn't helped. Expand NASDAQ : TTD The Trade Desk Today's Change ( ...
The acquisition of xAI by SpaceX has Tesla shareholders dreaming about convergence—one mega-Musk company leading the charge into an AI future. Tesla, SpaceX, and xAI head Elon Musk shocked the investment world Monday when he announced that SpaceX had acquired xAI, creating what he called “the most ambitious, vertically-integrated innovation engine on (and off) Earth.” “Current advances in AI are d...
The acquisition of xAI by SpaceX has Tesla shareholders dreaming about convergence—one mega-Musk company leading the charge into an AI future. Tesla, SpaceX, and xAI head Elon Musk shocked the investment world Monday when he announced that SpaceX had acquired xAI, creating what he called “the most ambitious, vertically-integrated innovation engine on (and off) Earth.” “Current advances in AI are dependent on large terrestrial data centers, which require immense amounts of power and cooling,” added Musk.
Deciding which stocks to buy is a big decision for any investor, but choosing when to buy can be just as hard. Nobody wants to buy a stock and immediately see their investment turn red on a loss. Yet, it's a reality investors must face. The truth is that nobody can time the markets. Sure, you might get lucky once or twice, but the better strategy is to think about companies that can grow over time...
Deciding which stocks to buy is a big decision for any investor, but choosing when to buy can be just as hard. Nobody wants to buy a stock and immediately see their investment turn red on a loss. Yet, it's a reality investors must face. The truth is that nobody can time the markets. Sure, you might get lucky once or twice, but the better strategy is to think about companies that can grow over time and buy the stocks when they are reasonably valued or cheap. The market has had a fantastic year, so most of the best companies seem expensive. That said, there are some exceptions. You can buy these three winning stocks at a reasonable price right now. The best part? You can buy a share of each for less than $1,000 all-in. Here they are: 1. Nvidia AI chip company Nvidia (NASDAQ: NVDA) keeps going up. The stock has risen more than 500% in just the past three years. Yet, there's still an argument for buying it today. The company has dominated the rapidly growing market for powerful chips used in data centers to train and operate artificial intelligence (AI) models. Nvidia has enjoyed jaw-dropping top and bottom line growth since early last year, which has fueled the stock's returns. Nvidia is reporting hot demand for Blackwell, its next-generation successor to the H100 series chip that has sold hand-over-fist for most of the past two years. The continued demand for Nvidia's AI chips has analysts estimating the company will grow its earnings by an average of 41% annually for the next three to five years as AI investments continue across the economy. The stock trades at a forward P/E of 48, which Nvidia's anticipated earnings growth justifies paying. Investors should look for warning signs of competitive pressure on Nvidia's near-monopoly on AI chips. Assuming Nvidia stays dominant, it's hard not to like the stock here. 2. Meta Platforms Social media giant Meta Platforms (NASDAQ: META) is becoming a potential AI juggernaut thanks to its co-founder and CEO Mark Zuckerberg, who...
The S&P 500 is hovering just below its all-time high of 7,002 as of Feb. 2. Yet with the market gripped by concerns about the monetization potential of the massive investments that tech companies are making in artificial intelligence (AI), many investors are worried that the rally may be coming to an end. Image source: Getty Images. Where to invest $1,000 right now? Our analyst team just revealed ...
The S&P 500 is hovering just below its all-time high of 7,002 as of Feb. 2. Yet with the market gripped by concerns about the monetization potential of the massive investments that tech companies are making in artificial intelligence (AI), many investors are worried that the rally may be coming to an end. Image source: Getty Images. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks » However, history shows that opening stakes in fundamentally strong businesses while they are trading at reasonable valuations is a smart long-term investment strategy. Chipmakers Micron Technology (NASDAQ: MU) and Taiwan Semiconductor Manufacturing (NYSE: TSM) both seem to fit the bill. Here's why investing $1,000 in either of these stocks could make sense for you in 2026. Micron Technology The memory chip market has long been cyclical, but after a difficult down phase in 2023 and 2024, Micron has staged a solid comeback, with high-bandwidth memory (a type of DRAM) emerging as one of its most significant AI-driven growth catalysts. In data center servers, high-bandwidth memory is positioned close to AI chips, where it provides those processors with the data they analyze in the training and deployment of increasingly large AI models. Micron has already locked in pricing and volume agreements for all the high-bandwidth memory it will produce in 2026, which gives the company impressive revenue visibility. However, demand for those chips is significantly higher than the available supply. The company is also preparing for the upcoming cycle, having shipped samples of its next-generation HBM4 memory products to key customers. Micron expects to be able to ramp up production of the HBM4 chips faster than it was able to do so with its HBM3E chips. It plans to start volume production in early this year and begin shipping them to customers in the second quarter. Supplies of DRAM (d...
(RTTNews) - Payroll processor ADP released a report on Wednesday showing private sector employment in the U.S. increased by much less than expected in the month of January. ADP said private sector employment rose by 22,000 jobs in January after climbing by a downwardly revised 37,000 jobs in December. Economists had expected private sector employment to grow by 45,000 jobs compared to the addition...
(RTTNews) - Payroll processor ADP released a report on Wednesday showing private sector employment in the U.S. increased by much less than expected in the month of January. ADP said private sector employment rose by 22,000 jobs in January after climbing by a downwardly revised 37,000 jobs in December. Economists had expected private sector employment to grow by 45,000 jobs compared to the addition of 41,000 jobs originally reported for the previous month. The modest increase in private sector employment largely reflected a jump in employment in the education and health services sector, which added 74,000 jobs. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Mission Wealth Management LP cut its holdings in Palantir Technologies Inc. (NASDAQ:PLTR - Free Report) by 45.6% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 11,754 shares of the company's stock after selling 9,860 shares during the quarter. Mission Wealth Management LP's holdings in Palantir Technologies were wort...
Mission Wealth Management LP cut its holdings in Palantir Technologies Inc. (NASDAQ:PLTR - Free Report) by 45.6% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 11,754 shares of the company's stock after selling 9,860 shares during the quarter. Mission Wealth Management LP's holdings in Palantir Technologies were worth $2,144,000 at the end of the most recent reporting period. A number of other institutional investors have also made changes to their positions in PLTR. Financial Consulate Inc. bought a new position in shares of Palantir Technologies in the third quarter worth about $30,000. Retirement Wealth Solutions LLC acquired a new stake in shares of Palantir Technologies in the third quarter valued at approximately $31,000. Flagship Wealth Advisors LLC bought a new position in Palantir Technologies in the 3rd quarter worth approximately $32,000. Marquette Asset Management LLC acquired a new position in Palantir Technologies during the 3rd quarter worth $34,000. Finally, Millstone Evans Group LLC lifted its holdings in Palantir Technologies by 98.0% during the 3rd quarter. Millstone Evans Group LLC now owns 198 shares of the company's stock worth $36,000 after buying an additional 98 shares in the last quarter. 45.65% of the stock is owned by institutional investors. Get Palantir Technologies alerts: Sign Up Wall Street Analysts Forecast Growth Several brokerages have recently issued reports on PLTR. Hsbc Global Res raised Palantir Technologies from a "hold" rating to a "strong-buy" rating in a research note on Tuesday. Wall Street Zen lowered shares of Palantir Technologies from a "buy" rating to a "hold" rating in a report on Friday, November 28th. CICC Research increased their price target on Palantir Technologies from $128.00 to $150.00 and gave the company a "neutral" rating in a research note on Wednesday, November 12th. Raymond James Financial reiterated a "market perform" ra...
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Waymo secured a $16b funding round valuing the Alphabet owned self driving unit at $126b. Alphabet, Sequoia, Dragoneer and other global investors participated, supporting a wider commercial rollout of autonomous ride hailing. Waymo plans to expand services to more than 20 cities, including m...
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Waymo secured a $16b funding round valuing the Alphabet owned self driving unit at $126b. Alphabet, Sequoia, Dragoneer and other global investors participated, supporting a wider commercial rollout of autonomous ride hailing. Waymo plans to expand services to more than 20 cities, including major new international markets, with regulators continuing to review safety and deployment rules. For Alphabet NasdaqGS:GOOGL, this funding event puts a spotlight on a business that sits outside its core search and advertising operations. The current share price of $339.71 comes alongside a 65.2% return over the past year and a 229.8% return over the past 5 years, which frames how investors have been valuing the broader group. Waymo’s new valuation gives you another data point when you think about how much of Alphabet’s market value might be tied to its so called “other bets.” Waymo’s push into more than 20 cities and into international markets could influence how you think about Alphabet’s exposure to autonomous mobility, regulation and capital intensity. As commercial services scale and regulatory decisions evolve, you may want to watch not only headline funding figures but also how management discusses Waymo’s impact on group level spending, partnerships and long term priorities. Stay updated on the most important news stories for Alphabet by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Alphabet. NasdaqGS:GOOGL 1-Year Stock Price Chart Why Alphabet could be great value Quick Assessment ⚖️ Price vs Analyst Target : At US$339.71, Alphabet trades about 1.9% below the US$346.32 analyst target, which sits comfortably inside the 10% band. ⚖️ Simply Wall St Valuation : Simply Wall St views Alphabet as trading close to estimated fair value, so this news may not shift the valuation case on its own. ✅ Recent Momentu...
DXP Enterprises ( DXPE ) on Wednesday said that it has completed the acquisition of Ambiente H2O, a manufacturer representative serving the water and wastewater industry. Ambiente, founded in 2006 and headquartered in Sheridan, Colorado, operates three locations across Colorado, Idaho, Montana, Utah, and Wyoming. The acquisition was funded with cash on DXP’s balance sheet. DXP said Ambiente genera...
DXP Enterprises ( DXPE ) on Wednesday said that it has completed the acquisition of Ambiente H2O, a manufacturer representative serving the water and wastewater industry. Ambiente, founded in 2006 and headquartered in Sheridan, Colorado, operates three locations across Colorado, Idaho, Montana, Utah, and Wyoming. The acquisition was funded with cash on DXP’s balance sheet. DXP said Ambiente generated sales of about $8.1 million in the twelve months ended December 31, 2025. The definitive agreement was signed on February 1, 2026. The acquisition expands DXP’s water and wastewater platform and establishes a presence in several western U.S. states. DXPE closed +2.48% at $137.78. Source: Press Release More on DXP Enterprises DXP Enterprises: Cash Is Strong, Growth Lagging, Wait For Signals Steven Cress Reviews His Top 10 Stocks For 2025 DXP Enterprises: A Rare Pullback Worth Buying DXP acquires Pump Solutions DXP Enterprises signals 11% EBITDA margin sustainability and strong 2026 outlook as water segment drives growth
Keir Starmer has confirmed for the first time he knew about Peter Mandelson’s longer-term relationship with Jeffrey Epstein before appointing him US ambassador, saying the peer had “lied repeatedly” about the extent of his contact with the child sex offender. Questioned repeatedly at prime minister’s questions, Starmer said Mandelson had “betrayed our country” in his dealings with Epstein. “He lie...
Keir Starmer has confirmed for the first time he knew about Peter Mandelson’s longer-term relationship with Jeffrey Epstein before appointing him US ambassador, saying the peer had “lied repeatedly” about the extent of his contact with the child sex offender. Questioned repeatedly at prime minister’s questions, Starmer said Mandelson had “betrayed our country” in his dealings with Epstein. “He lied repeatedly to my team, when asked about his relationship with Epstein before and during his tenure as ambassador,” the prime minister said. “I regret appointing him. If I knew then what I know now, he would never been anywhere near government.” Saying that Mandelson was now being investigated by police over his apparent leaking of market-sensitive information and Downing Street emails to Epstein while serving in Gordon Brown’s government, Starmer said Mandelson had been removed as a privy councillor and there were also moves to strip him of his peerage. He said: “This morning, I have agreed with his majesty the king that Mandelson should be removed from the list of privy councillors on grounds that he brought the reputation of the privy council into disrepute.” Senior ministers are routinely made members of the privy council, a historical body that used to advise the monarch, and remain so for life. Saying his thoughts were with Epstein’s victims, Starmer added: “Can I also say our thoughts are with all those who lost jobs, savings and livelihoods in the aftermath of the 2008 financial crash. To learn that there was a cabinet minister leaking sensitive information at the height of the response to the 2008 crash is beyond infuriating, and I’m as angry as the public and any member of this house.” Mandelson, he went on, “betrayed our country, our parliament and my party”. Questioned repeatedly by Kemi Badenoch, the Conservative leader, about what he knew regarding Mandelson’s ties to Epstein before appointing the peer US ambassador, Starmer acknowledged he knew – as had been...
MGIC Investment Corp. (Symbol: MTG) has been named as a Top 25 dividend stock, according the most recent Dividend Channel report. The report noted that among the coverage universe, MTG shares displayed both attractive valuation metrics and strong profitability metrics. The report also cited the strong quarterly dividend history at MGIC Investment Corp., and favorable long-term multi-year growth ra...
MGIC Investment Corp. (Symbol: MTG) has been named as a Top 25 dividend stock, according the most recent Dividend Channel report. The report noted that among the coverage universe, MTG shares displayed both attractive valuation metrics and strong profitability metrics. The report also cited the strong quarterly dividend history at MGIC Investment Corp., and favorable long-term multi-year growth rates in key fundamental data points. The report stated, ''Dividend investors approaching investing from a value standpoint are generally most interested in researching the strongest most profitable companies, that also happen to be trading at an attractive valuation. That's what we aim to find using our proprietary DividendRank formula, which ranks the coverage universe based upon our various criteria for both profitability and valuation, to generate a list of the top most 'interesting' stocks, meant for investors as a source of ideas that merit further research.'' The annualized dividend paid by MGIC Investment Corp. is $0.6/share, currently paid in quarterly installments, and its most recent dividend ex-date was on 02/17/2026. Below is a long-term dividend history chart for MTG, which the report stressed as being of key importance. Indeed, studying a company's past dividend history can be of good help in judging whether the most recent dividend is likely to continue. The Top 25 DividendRank'ed Stocks » Also see: The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.